Clinical Trial Results
Research Sponsor: MedImmune, LLC
Vaccine Studied: FluMist Quadrivalent
National Clinical Trial #: NCT02743117
Protocol #: D2560C00012
Study Date: May 2016 to November 2016
Short Study Title: A study to determine the safety of a new investigational form of FluMist in healthy adults
Thank you!
As a clinical study participant, you belong to a large community of participants around the world. You help researchers answer important health questions and discover new medical treatments.
Thank you for taking part in the clinical study for a new form of FluMist.
This vaccine is being developed to prevent influenza, or the flu. You and all of the other participants helped researchers learn if this form of FluMist is safe to take.
MedImmune, LLC, the sponsor of this study, thanks you for your help and thinks it is important for you to know the results of your study. An independent non-profit organization called CISCRP prepared this summary of the study results for you, with the help of a medical writing organization.
We hope it helps you understand and feel proud of your important role in medical research. If you have questions about the results, please speak with the doctor or staff at your study site.